company background image
ADVENT logo

Advent Pharma DSE:ADVENT Stock Report

Last Price

৳16.70

Market Cap

৳1.6b

7D

1.2%

1Y

-30.7%

Updated

30 Dec, 2024

Data

Company Financials

Advent Pharma Ltd.

DSE:ADVENT Stock Report

Market Cap: ৳1.6b

ADVENT Stock Overview

A pharmaceutical company, manufactures, imports, and markets animal health care drugs, nutritional supplements, and feed additives for livestock in Bangladesh. More details

ADVENT fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance1/6
Financial Health5/6
Dividends2/6

Risk Analysis

Earnings have declined by 11.6% per year over past 5 years

Does not have a meaningful market cap (BDT2B)

Volatile share price over the past 3 months compared to the BD market

Does not have meaningful revenue (BDT522M)


My Notes

Capture your thoughts, links and company narrative

Advent Pharma Ltd. Competitors

Ambee Pharmaceuticals

DSE:AMBEEPHA

৳1.7b

Silco Pharmaceuticals

DSE:SILCOPHL

৳1.7b

Techno Drugs

DSE:TECHNODRUG

৳4.7b

Navana Pharmaceuticals

DSE:NAVANAPHAR

৳5.2b

Price History & Performance

Summary of share price highs, lows and changes for Advent Pharma
Historical stock prices
Current Share Price৳16.70
52 Week High৳35.60
52 Week Low৳13.90
Beta0.43
1 Month Change0%
3 Month Change-7.73%
1 Year Change-30.71%
3 Year Change-35.96%
5 Year Change-15.60%
Change since IPO-53.16%

Recent News & Updates

Recent updates

Shareholder Returns

ADVENTBD PharmaceuticalsBD Market
7D1.2%-0.3%0.7%
1Y-30.7%-25.8%-21.2%

Return vs Industry: ADVENT underperformed the BD Pharmaceuticals industry which returned -26.1% over the past year.

Return vs Market: ADVENT underperformed the BD Market which returned -21.2% over the past year.

Price Volatility

Is ADVENT's price volatile compared to industry and market?
ADVENT volatility
ADVENT Average Weekly Movement8.0%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement6.4%
10% most volatile stocks in BD Market8.7%
10% least volatile stocks in BD Market3.4%

Stable Share Price: ADVENT's share price has been volatile over the past 3 months compared to the BD market.

Volatility Over Time: ADVENT's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of BD stocks.

About the Company

FoundedEmployeesCEOWebsite
2007312Faria Alamwww.adventpharmabd.com

Advent Pharma Ltd., a pharmaceutical company, manufactures, imports, and markets animal health care drugs, nutritional supplements, and feed additives for livestock in Bangladesh. The company offers poultry, aquaculture, and cattle products. It provides its products in powder, bolus, and liquid dosage forms.

Advent Pharma Ltd. Fundamentals Summary

How do Advent Pharma's earnings and revenue compare to its market cap?
ADVENT fundamental statistics
Market cap৳1.56b
Earnings (TTM)৳66.62m
Revenue (TTM)৳522.06m

23.3x

P/E Ratio

3.0x

P/S Ratio

Is ADVENT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ADVENT income statement (TTM)
Revenue৳522.06m
Cost of Revenue৳319.70m
Gross Profit৳202.36m
Other Expenses৳135.74m
Earnings৳66.62m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.72
Gross Margin38.76%
Net Profit Margin12.76%
Debt/Equity Ratio5.1%

How did ADVENT perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

14%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 00:18
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Advent Pharma Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution